These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant. Forastiero RR; Falcón CR; Carreras LO Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955 [TBL] [Abstract][Full Text] [Related]
3. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1). Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977 [TBL] [Abstract][Full Text] [Related]
4. A lupus anticoagulant neutralization procedure using the patient's own platelets. Carroll P; Ray M; Just S; Hawson G Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308 [TBL] [Abstract][Full Text] [Related]
6. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant. Exner T; Low J Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290 [TBL] [Abstract][Full Text] [Related]
7. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism. Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313 [TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107 [TBL] [Abstract][Full Text] [Related]
9. Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity. Rolla R; Vidali M; Serino R; Pergolini P; Albano E; Bellomo G Clin Exp Immunol; 2007 Jul; 149(1):63-9. PubMed ID: 17488295 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection]. Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068 [TBL] [Abstract][Full Text] [Related]
11. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants. Alving BM; Barr CF; Johansen LE; Tang DB Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408 [TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of lupus anticoagulants--effect of residual platelets in plasma, assessed by Staclot LA and silica clotting time. Chantarangkul V; Tripodi A; Clerici M; Bressi C; Mannucci PM Thromb Haemost; 2002 May; 87(5):854-8. PubMed ID: 12038789 [TBL] [Abstract][Full Text] [Related]
13. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing. Genzen JR; Miller JL Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions. Martin BA; Branch DW; Rodgers GM Blood Coagul Fibrinolysis; 1996 Jan; 7(1):31-8. PubMed ID: 8845460 [TBL] [Abstract][Full Text] [Related]
15. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations. Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024 [TBL] [Abstract][Full Text] [Related]
16. [Transitions of each inhibitor in a patient with lupus anticoagulant and anti-prothrombin antibody]. Murakami F; Iijima K; Nakamura K; Ikawa S; Hayashibara H; Siraki K Rinsho Byori; 1996 Jul; 44(7):692-6. PubMed ID: 8741501 [TBL] [Abstract][Full Text] [Related]
17. Testing strategies for diagnosing lupus anticoagulant: decision analysis. Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765 [TBL] [Abstract][Full Text] [Related]
18. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant. Dragoni F; Minotti C; Palumbo G; Faillace F; Redi R; Bongarzoni V; Avvisati G Thromb Res; 2001 Jan; 101(2):45-51. PubMed ID: 11342205 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I. Matsuda J; Gohchi K; Tsukamoto M; Saitoh N; Asami K; Hashimoto M Am J Hematol; 1993 Nov; 44(3):187-91. PubMed ID: 8213768 [TBL] [Abstract][Full Text] [Related]
20. Comparison of a platelet neutralization procedure with a hexagonal phase phospholipid neutralization assay as confirmatory tests for the presence of lupus anticoagulants. Reber G; Roisin JP; Migaud M; de Moerloose P Thromb Res; 1994 Jan; 73(2):131-5. PubMed ID: 8171412 [No Abstract] [Full Text] [Related] [Next] [New Search]